ONCS signs cGMP manufacturing agreement with VGXI
The agreement uses VGXI’s patented DNA plasmid manufacturing process and leverages VGXI’s expertise for large-scale process development and clinical manufacturing for DNA IL-12 for use in OncoSec’s OMS